S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

NCT00336947 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: tegafur-gimeracil-oteracil potassium
DRUG: tegafur-uracil
PROCEDURE: adjuvant therapy

Sponsor

Yokohama City University